133 related articles for article (PubMed ID: 9708647)
1. Cisplatin-based chemotherapy for testicular cancer in a patient with spinal muscular atrophy: a case report.
Sokol DB; Hudes GR
Am J Clin Oncol; 1998 Aug; 21(4):420-1. PubMed ID: 9708647
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment on: paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Salonia A
Eur Urol; 2010 Jul; 58(1):140-1. PubMed ID: 20395038
[No Abstract] [Full Text] [Related]
3. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
4. Fertility after chemotherapy for testicular germ cell cancer.
Pont J; Albrecht W
Fertil Steril; 1997 Jul; 68(1):1-5. PubMed ID: 9207575
[TBL] [Abstract][Full Text] [Related]
5. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
Bokemeyer C
Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
von Schlippe M; Fowler CJ; Harland SJ
Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
[TBL] [Abstract][Full Text] [Related]
7. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
8. [Long-term side effects of chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
[TBL] [Abstract][Full Text] [Related]
9. Testicular cancer: risks of treatment vs risks of recurrence.
Bonn D
Lancet Oncol; 2002 Apr; 3(4):197. PubMed ID: 12067668
[No Abstract] [Full Text] [Related]
10. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors.
Vuky J; McCaffrey J; Ginsberg M; Mariani T; Bajorin DF; Bosl GJ; Motzer RJ
Invest New Drugs; 2000 Aug; 18(3):265-7. PubMed ID: 10958596
[TBL] [Abstract][Full Text] [Related]
12. Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.
Mayer F; Honecker F; Looijenga LH; Bokemeyer C
Ann Oncol; 2003 Jun; 14(6):825-32. PubMed ID: 12796018
[TBL] [Abstract][Full Text] [Related]
13. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Soulié P; Garrino C; Bensmaïne MA; Bekradda M; Brain E; Di Palma M; Goupil A; Misset JL; Cvitkovic E
J Cancer Res Clin Oncol; 1999 Dec; 125(12):707-11. PubMed ID: 10592105
[TBL] [Abstract][Full Text] [Related]
14. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
15. Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone.
Papadimitris C; Papadimitriou C; Kokolakis N; Athanassiades P; Dimopoulos MA
Urology; 1997 Mar; 49(3):469-70. PubMed ID: 9123720
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-based chemotherapy in a renal transplant recipient with metastatic germ cell testicular cancer.
Dahl O; Vagstad G; Iversen B
Acta Oncol; 1996; 35(6):759-61. PubMed ID: 8938228
[No Abstract] [Full Text] [Related]
17. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours.
Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP
BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
[TBL] [Abstract][Full Text] [Related]
19. Testicular sperm extraction in azoospermic patients with gonadal germ cell tumors prior to chemotherapy--a new therapy option.
Schrader M; Muller M; Straub B; Miller K
Asian J Androl; 2002 Mar; 4(1):9-15. PubMed ID: 11907623
[TBL] [Abstract][Full Text] [Related]
20. Successful management of inferior vena cava thrombus complicating advanced germ cell testicular tumor with temporary inferior vena cava filter.
Masui S; Onishi T; Arima K; Sugimura Y
Int J Urol; 2005 May; 12(5):513-5. PubMed ID: 15948757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
